The GLP-1 Receptor Agonist Liraglutide Attenuates Atherosclerotic Lesion Development and Potentially Enhances Plaque Stability in an ApoE–/–Mouse Model

Research output: Contribution to conferenceOther

Original languageEnglish
Number of pages1
Publication statusPublished - 2013

Cite this